The management of Charcot joint disease affecting the ankle and foot by arthrodesis controlled by an Ilizarov frame: Early results

Journal of Bone and Joint Surgery - Series B

Volumn 91, Issue 10, 2009, Pages 1322-1325

  El Gafary, K A M ^a   Mostafa, K M ^a   Al adly, W Y ^a  

^a ASSIUT UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANKLE ARTHRODESIS; ARTHRODESIS; ARTICLE; BONE GRAFT; BONE NECROSIS; CLINICAL ARTICLE; DIABETES MELLITUS; EXTERNAL FIXATOR; FEMALE; FOOT ULCER; HUMAN; ILIAC CREST; ILIZAROV TECHNIQUE; MALE; NEUROPATHIC JOINT DISEASE; OSTEOARTHROPATHY; PRIORITY JOURNAL; ULCER HEALING;

ADULT; ANKLE JOINT; ARTHRODESIS; ARTHROPATHY, NEUROGENIC; EXTERNAL FIXATORS; FEMALE; FOOT; HUMANS; ILIZAROV TECHNIQUE; MALE; MIDDLE AGED; RANGE OF MOTION, ARTICULAR; TREATMENT OUTCOME; WEIGHT-BEARING; YOUNG ADULT;

EID: 70349668969     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.91B10.22431     Document Type: Article

References (17)

1. Young MJ, Marshall AB, Adams JE, Boulton AJM. Osteopenia, neurological dysfunction and the development of Charcot neuroarthropathy. Diabetes Care 1995;18:34-38
2. Sanders LJ. The Charcot foot: historical perspective 1827-2003. Diabetes Metab Res Rev 2004;20(Suppl):4-8.
3. Armstrong DG, Todd WF, Lavery LA, Harkless LB, Bushman TR. The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic. Diabet Med 1997;14:357-363 (Pubitemid 27248015)
4. Jeffcoate WJ. Abnormalities of vasomotor regulation in the pathogenesis of the acute charcot foot of diabetes mellitus. Int J Lower Extrem Wounds 2005;4:133-137
5. Jeffcoate WJ, Game F, Cavanagh PR. The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy in diabetes. Lancet 2005;10:2058-2061 (Pubitemid 41773381)
6. Jeffcoate WJ. Theories concerning the pathogenesis of the acute Charcot foot suggest future therapy. Curr Diab Rep 2005;5:430-435
7. Richardson EG. Diabetic foot. In: Canale ST, ed. Campbell's operative orthopaedics. Ninth ed. London: Mosby, 1998.
8. Wagner FW. The diabetic foot. Orthopedics 1987;10:163.
9. Eichenholtz SN. Charcot joints. Springfield, IL: Charles C Thomas, 1966.
10. Shibata T, Tada K, Hashizume C. The results of arthrodesis of the ankle for leprotic neuroarthropathy. J Bone Joint Surg [Am] 1990;72-A:749-756
11. Bradley L, Lamm, Paley D. Charcot neuroarthropathy of the foot and ankle in limb lengthening and reconstruction surgery. In: Rozbruch SR, Ilizarov S, eds. Limb lengthening and reconstruction surgery. Vol.1. London: Informa Healthcare, 2007:221-232
12. Armstrong DG, Lavery LA, Harkless LB. Who is at risk for diabetic foot ulceration? Clin Podiat Med Surg 1998;15:11-19. (Pubitemid 28072926)
13. Armstrong DG, Lavery LA. Elevated peak plantar pressures in patients who have Charcot arthropathy. J Bone Joint Surg [Am] 1998;80-A:365-369
14. Simon SR, Tejwani SG, Wilson DL, Santner TJ, Denniston NL. Arthrodesis as an early alternative to non-operative management of Charcot arthropathy of the diabetic foot. J Bone Joint Surg [Am] 2000;82-A:939-950
15. Wang JC, Le AW, Tsukuda RK. A new technique for Charcot's foot reconstruction. J Am Podiatr Med Assoc 2002;92:429-436
16. Cooper PS. Application of external fixator for management of Charcot deformities of the foot and ankle. Foot Ankle Clin 2002;7:207-254
17. Farber DC, Juliano PJ, Cavanagh PR, Ulbrecht J, Caputo G. Single stage correction with external fixation of the ulcerated foot in indivuduals with Charcot neuroarthropathy. Foot Ankle Int 2002;23:130-134 (Pubitemid 34157732)